These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37766217)

  • 1. Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial.
    Fellows T; Page N; Fix A; Flores J; Cryz S; McNeal M; Iturriza-Gomara M; Groome MJ
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial.
    Groome MJ; Fairlie L; Morrison J; Fix A; Koen A; Masenya M; Jose L; Madhi SA; Page N; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S
    Lancet Infect Dis; 2020 Jul; 20(7):851-863. PubMed ID: 32251641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.
    Groome MJ; Koen A; Fix A; Page N; Jose L; Madhi SA; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S
    Lancet Infect Dis; 2017 Aug; 17(8):843-853. PubMed ID: 28483414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma VP8∗-Binding Antibodies in Rotavirus Infection and Oral Vaccination in Young Bangladeshi Children.
    Lee B; Colgate ER; Carmolli M; Dickson DM; Gullickson S; Diehl SA; Ara R; Alam M; Kibria G; Abdul Kader M; Afreen S; Ferdous T; Haque R; Kirkpatrick BD
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):127-133. PubMed ID: 34904667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial.
    Lee B; Dickson DM; Alam M; Afreen S; Kader A; Afrin F; Ferdousi T; Damon CF; Gullickson SK; McNeal MM; Bak DM; Tolba M; Carmolli MP; Taniuchi M; Haque R; Kirkpatrick BD
    Vaccine; 2020 Jan; 38(1):90-99. PubMed ID: 31607603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults.
    Fix AD; Harro C; McNeal M; Dally L; Flores J; Robertson G; Boslego JW; Cryz S
    Vaccine; 2015 Jul; 33(31):3766-72. PubMed ID: 26065919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh.
    Lee B; Carmolli M; Dickson DM; Colgate ER; Diehl SA; Uddin MI; Islam S; Hossain M; Rafique TA; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; McNeal MM; Petri WA; Qadri F; Haque R; Kirkpatrick BD
    Clin Infect Dis; 2018 Jul; 67(2):186-192. PubMed ID: 29394355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies.
    Li RC; Li YP; Mo ZJ; Luo D; Huang T; Kong JL; Wang LH; Song NS; Liu A; Zhang H; Liao X; Karkada N; Han HH
    Hum Vaccin Immunother; 2013 Aug; 9(8):1638-42. PubMed ID: 23807360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of P[8], P[4], and P[6] VP8* genes of human rotaviruses globally reported during 1974 and 2017: possible implications for rotavirus vaccines in development.
    Velasquez DE; Jiang B
    Hum Vaccin Immunother; 2019; 15(12):3003-3008. PubMed ID: 31124743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
    Ella R; Babji S; Ciarlet M; Blackwelder WC; Vadrevu KM
    Vaccine; 2019 Jul; 37(31):4407-4413. PubMed ID: 31178377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial.
    Bines JE; Danchin M; Jackson P; Handley A; Watts E; Lee KJ; West A; Cowley D; Chen MY; Barnes GL; Justice F; Buttery JP; Carlin JB; Bishop RF; Taylor B; Kirkwood CD;
    Lancet Infect Dis; 2015 Dec; 15(12):1389-97. PubMed ID: 26318715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral tetravalent rotavirus vaccine can be successfully coadministered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine. US Rhesus Rotavirus Vaccine Study Group.
    Markwick AJ; Rennels MB; Zito ET; Wade MS; Mack ME
    Pediatr Infect Dis J; 1998 Oct; 17(10):913-8. PubMed ID: 9802635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial.
    Velasquez-Portocarrero DE; Wang X; Cortese MM; Snider CJ; Anand A; Costantini VP; Yunus M; Aziz AB; Haque W; Parashar U; Sisay Z; Soeters HM; Hyde TB; Jiang B; Zaman K
    Lancet Infect Dis; 2022 Nov; 22(11):1606-1616. PubMed ID: 35961362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical Trial.
    Middleton BF; Danchin M; Jones MA; Leach AJ; Cunliffe N; Kirkwood CD; Carapetis J; Gallagher S; Kirkham LA; Granland C; McNeal M; Marsh JA; Waddington CS; Snelling TL
    J Infect Dis; 2022 Nov; 226(9):1537-1544. PubMed ID: 35134951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA-Based Vaccines Are Highly Immunogenic and Confer Protection in the Gnotobiotic Pig Model of Human Rotavirus Diarrhea.
    Hensley C; Roier S; Zhou P; Schnur S; Nyblade C; Parreno V; Frazier A; Frazier M; Kiley K; O'Brien S; Liang Y; Mayer BT; Wu R; Mahoney C; McNeal MM; Petsch B; Rauch S; Yuan L
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception.
    Singh T; Delannois F; Haguinet F; Molo LY
    Drug Saf; 2022 Feb; 45(2):155-168. PubMed ID: 35015268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines.
    Wen X; Wen K; Cao D; Li G; Jones RW; Li J; Szu S; Hoshino Y; Yuan L
    Vaccine; 2014 Jul; 32(35):4420-4427. PubMed ID: 24962749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants.
    Lazarus RP; John J; Shanmugasundaram E; Rajan AK; Thiagarajan S; Giri S; Babji S; Sarkar R; Kaliappan PS; Venugopal S; Praharaj I; Raman U; Paranjpe M; Grassly NC; Parker EPK; Parashar UD; Tate JE; Fleming JA; Steele AD; Muliyil J; Abraham AM; Kang G
    Vaccine; 2018 Jan; 36(2):273-279. PubMed ID: 28874323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants.
    Cohet C; Cheuvart B; Moerman L; Bi D; Caplanusi A; Kariyappa M; Lalwani S; Mitra M; Sapru A; Saha S; Varughese PV; Kompithra RZ; Gandhi S
    Hum Vaccin Immunother; 2021 Nov; 17(11):4646-4653. PubMed ID: 34428112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.